Trials / Completed
CompletedNCT00241085
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
A Multi-center, Double Blind, Randomized, Parallel Group Study to Evaluate the Effects of Valsartan on Proteinuria in Hypertensive Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 392 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a study of whether valsartan affects levels of proteinuria in patients with type 2 diabetes and hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valsartan |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2005-10-18
- Last updated
- 2011-11-08
Source: ClinicalTrials.gov record NCT00241085. Inclusion in this directory is not an endorsement.